Translation and cultural adaptation of the Breast Cancer Treatment Outcome Scale (BCTOS) into Brazilian Portuguese

SUMMARY BACKGROUND: Breast conservative treatment (BCT) is safe when it is performed in association with radiotherapy. The number of referral for BCT has increased, and it has become an important treatment modality. Patients who undergo BCT present some characteristics that are associated with better quality of life compared with patients who undergo mastectomy without reconstruction. Instruments that measure the quality of life specifically used in cases of BCT are limited. One of these instruments is the Breast Cancer Treatment Outcome Scale (BCTOS), which has not yet been translated into Brazilian Portuguese. It contains 22 questions and four domains (functional, aesthetic, breast sensitivity and oedema). METHODS: We performed the translation and cultural adaptation process using Beaton's and EORTC translations process. In summary, the translation process is based on Portuguese translation, translation summary, reverse translation into English, expert committee, pre-test (10 patients), questionnaire review and test of the final version (6 patients). RESULTS: All 16 patients were submitted to quadrantectomy and mammary radiotherapy. Lymphedema was present in 4, altered strength in 5, and altered shoulder mobility in 6 patients. Considering the questionnaire, the reconciled version determined change in 2 items. Pre-test evaluation showed difficulties in 3 patients, but the questionnaire did not change. Test evaluation showed no problems. CONCLUSION: The translation of BCTOS into Portuguese will help us to evaluate the quality of life in BCT patients evaluating treatment-related sequelae and may be useful for oncoplastic surgery evaluation.

Download Full-text

Aesthetic and functional results of quality of life after breast conserving surgery evaluated by Portuguese/Brazil version of breast cancer treatment outcome scale (BCTOS)

The Breast ◽

10.1016/s0960-9776(17)30408-3 ◽

2017 ◽

Vol 32 ◽

pp. S131 ◽

Cited By ~ 1

Author(s):

R. Costa Vieira ◽

F. Brandini Silva ◽

J. da Silva ◽

L. Ferreira ◽

J. Santos Paulista ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Treatment Outcome ◽

Cancer Treatment ◽

Functional Results ◽

Breast Conserving Surgery ◽

Breast Cancer Treatment

Download Full-text

Comprehensive Validation Study of Quality-of-Life Questionnaire Using Objective Clinical Measures: Breast Cancer Treatment Outcome Scale (BCTOS), Brazilian Portuguese Version

Clinical Breast Cancer ◽

10.1016/j.clbc.2018.10.004 ◽

2019 ◽

Vol 19 (1) ◽

pp. e85-e100 ◽

Cited By ~ 4

Author(s):

Fabíola Cristina Brandini da Silva ◽

Jonathas José da Silva ◽

Almir José Sarri ◽

Carlos Eduardo Paiva ◽

René Aloisio da Costa Vieira

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Treatment Outcome ◽

Validation Study ◽

Breast Cancer Treatment ◽

Brazilian Portuguese ◽

Life Questionnaire ◽

Quality Of Life Questionnaire ◽

Clinical Measures

Download Full-text

Aesthetic and functional results after breast conserving surgery as correlates of quality of life measured by a German version of the Breast Cancer Treatment Outcome Scale (BCTOS)

The Breast ◽

10.1016/j.breast.2010.05.004 ◽

2010 ◽

Vol 19 (6) ◽

pp. 470-474 ◽

Cited By ~ 34

Author(s):

Joerg Heil ◽

Simone Holl ◽

Michael Golatta ◽

Geraldine Rauch ◽

Joachim Rom ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Treatment Outcome ◽

Cancer Treatment ◽

Functional Results ◽

Breast Conserving Surgery ◽

Breast Cancer Treatment ◽

German Version

Download Full-text

Re: Measuring Surgery-Specific Aspects of Quality of Life in Oncologic Breast Surgery-Measuring Aesthetic and Functional Outcome Using the BCTOS (Breast Cancer Treatment Outcome Scale)

The Breast Journal ◽

10.1111/j.1524-4741.2011.01108.x ◽

2011 ◽

Vol 17 (4) ◽

pp. 441-442 ◽

Cited By ~ 3

Author(s):

Joerg Heil ◽

Annette L. Stanton

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Treatment Outcome ◽

Cancer Treatment ◽

Functional Outcome ◽

Breast Surgery ◽

Breast Cancer Treatment

Download Full-text

The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment

npj Breast Cancer ◽

10.1038/s41523-021-00276-y ◽

2021 ◽

Vol 7 (1) ◽

Author(s):

Mads G. Jørgensen ◽

Navid M. Toyserkani ◽

Frederik G. Hansen ◽

Anette Bygum ◽

Jens A. Sørensen

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Cancer Treatment ◽

Breast Cancer Treatment ◽

Health Related Quality ◽

Related Quality ◽

Health Related ◽

The Impact

AbstractThe impact of breast cancer-related lymphedema (BCRL) on long-term quality of life is unknown. The aim of this study was to investigate the impact of BCRL on health-related quality of life (HRQoL) up to 10 years after breast cancer treatment. This regional population-based study enrolled patients treated for breast cancer with axillary lymph node dissection between January 1st 2007 and December 31th 2017. Follow up and assessments of the included patients were conducted between January 2019 and May 2020. The study outcome was HRQoL, evaluated with the Lymphedema Functioning, Disability and Health Questionnaire, the Disabilities of the Arm, Shoulder and Hand Questionnaire and the Short Form (36) Health Survey Questionnaire. Multivariate linear logistic regression models adjusted for confounders provided mean score differences (MDs) with 95% confidence intervals in each HRQoL scale and item. This study enrolled 244 patients with BCRL and 823 patients without BCRL. Patients with BCRL had significantly poorer HRQoL than patients without BCRL in 16 out of 18 HRQoL subscales, for example, in physical function (MDs 27, 95%CI: 24; 30), mental health (MDs 24, 95%CI: 21; 27) and social role functioning (MDs 20, 95%CI: 17; 23). Age, BMI, BCRL severity, hand and dominant arm affection had only minor impact on HRQoL (MDs < 5), suggesting a high degree of inter-individual variation in coping with lymphedema. This study showed that BCRL is associated with long-term impairments in HRQoL, especially affecting the physical and psychosocial domains. Surprisingly, BCRL diagnosis rather than clinical severity drove the largest impairments in HRQoL.

Download Full-text

Improving the quality of life of patients with breast cancer-related lymphoedema by lymphaticovenous anastomosis (LVA): study protocol of a multicentre randomised controlled trial

BMJ Open ◽

10.1136/bmjopen-2019-035337 ◽

2020 ◽

Vol 10 (1) ◽

pp. e035337 ◽

Cited By ~ 1

Author(s):

Joost Wolfs ◽

Jop Beugels ◽

Merel Kimman ◽

Andrzej A Piatkowski de Grzymala ◽

Esther Heuts ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Lymph Node ◽

Randomised Controlled Trial ◽

Conservative Treatment ◽

Cancer Treatment ◽

Controlled Trial ◽

Breast Cancer Treatment ◽

Randomised Controlled

IntroductionEarly breast cancer detection and advancements in treatment options have resulted in an increase of breast cancer survivors. An increasing number of women are living with the long-term effects of breast cancer treatment, making the quality of survivorship an increasingly important goal. Breast cancer-related lymphoedema (BCRL) is one of the most underestimated complications of breast cancer treatment with a reported incidence of 20%. A microsurgical technique called lymphaticovenous anastomosis (LVA) might be a promising treatment modality for patients with BCRL. The main objective is to assess whether LVA is more effective than the current standard therapy (conservative treatment) in terms of improvement in quality of life and weather it is cost-effective.Methods and analysisA multicentre, randomised controlled trial, carried out in two academic and two community hospitals in the Netherlands. The study population includes 120 women over the age of 18 who have undergone treatment for breast cancer including axillary treatment (sentinel lymph node biopsy or axillary lymph node dissection) and/or axillary radiotherapy, presenting with an early stage lymphoedema of the arm, viable lymphatic vessels and received at least 3 months conservative treatment. Sixty participants will undergo the LVA operation and the other sixty will continue their regular conservative treatment, both with a follow-up of 24 months. The primary outcome is the health-related quality of life. Secondary outcomes are societal costs, quality adjusted life years, cost-effectiveness ratio, discontinuation rate of conservative treatment and excess limb volume.Ethics and disseminationThe study was approved by the Ethics Committee of Maastricht University Medical Center (METC) on 19 December 2018 (NL67059.068.18). The results of this study will be disseminated in presentations at academic conferences, publications in peer-reviewed journals and other news media.Trial registration numberNCT02790021; Pre-results.

Download Full-text